N@N

ROCHESTER MEDICAL CORPORATION (NASDAQ:ROCM), Up By 5.31% ($0.55) After BUYINS.NET SqueezeTrigger Report Released on Friday, Aug

^{Published on 2012-08-20 07:40:56 - WOPRAI}
 

August 20, 2012 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, released a report on Friday, August 17th 2012 at 09:16:00 PDT stating that ROCHESTER MEDICAL CORPORATION (NASDAQ:ROCM) was expected to be Up After it crossed above its SqueezeTrigger Price of 10.34 on Friday, August 17th 2012. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=rocm&id=301650

From August 2009 to July 2012, an aggregate amount of 7294872 shares of ROCM have been shorted for a total dollar value of $72948720. The ROCM SqueezeTrigger price of $10.34 is the volume weighted average price that all shorts are short in shares of ROCM. There is still approximately $4,340,972 of potential short covering in shares of ROCM.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger Price for each stock that has been shorted. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of short squeeze events. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com .

ROCHESTER MEDICAL CORPORATION (NASDAQ:ROCM) - Rochester Medical Corporation develops, manufactures, and markets urinary continence and urine drainage care products for the home care and acute/extended care markets in the United States, Europe, and internationally. Its extended care products include a line of male external catheters for managing male urinary incontinence and a line of intermittent catheters for managing male and female urinary retention. The companys extended care products also comprise personal catheters, a line of disposable intermittent catheters manufactured from silicone in three lengths with multiple diameters for male, female, and pediatric use; and theFemSoft Insert, a liquid-filled urethral insert for managing female stress urinary incontinence in adult females. Its acute care products consist of a line of Foley catheters, including StrataSI and StrataNF silicone Foley catheters that reduces the incidence of hospital acquired urinary tract infection, or UTI. The company offers silicone Foley catheters in a two-lumen version for urinary drainage management and in a three-lumen version that also supports irrigation of the urinary tract. It also provides antibacterial and hydrophilic intermittent catheters. In addition, the company sells two models of latex male external catheters. Rochester Medical Corporation markets its products under the Rochester Medical brand name to distributors, extended care facilities, and individual hospitals and healthcare institutions through a direct sales force in the United States and United Kingdom, and through independent distributors in other international markets. The company was founded in 1988 and is based in Stewartville, Minnesota.

The SqueezeTrigger database of approximately 1 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net